ISSN: 1949-2553
Publisher: Impact Journals


Go to first page Go to previous page 1 of 8 Go to next page Go to last page

Journal issue: 40, Volume: 10, Pages range: 3994-3995
Advanced MRI in neuro-oncology: Can we proceed without inclusion of energy metabolism? (2019)
Stadlbauer A, Buchfelder M, Dörfler A, et al.

Journal issue: 19, Volume: 10, Pages range: 1812-1828
Characterization of CD4+ T cells primed and boosted by MHCII primary uveal melanoma cell-based vaccines (2019)
Kittler J, Sommer J, Fischer A, et al.

Journal issue: 50, Volume: 10, Pages range: 5217-5228
Increased expression of cathepsin D is required for L1-mediated colon cancer progression (2019)
Basu S, Cheriyamundath S, Gavert N, et al.

Journal issue: 41, Volume: 9, Pages range: 26543-26555
Characterization and diagnostic application of genomic NPM-ALK fusion sequences in anaplastic large-cell lymphoma (2018)
Krumbholz M, Woessmann W, Zierk J, et al.

Journal issue: 47, Volume: 9, Pages range: 28772-28783
Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients (2018)
Regnery S, Adeberg S, Dreher C, et al.

Journal issue: 3, Volume: 9, Pages range: 3605-3618
Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic "dual-hit" option (2018)
Dietrich P, Freese K, Mahli A, et al.

Journal issue: 17, Volume: 9, Pages range: 13125-13138
IL-21 modulates memory and exhaustion phenotype of T-cells in a fatty acid oxidation-dependent manner (2018)
Loschinski R, Böttcher M, Stoll A, et al.

Journal issue: 48, Volume: 9, Pages range: 28903-28909
Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patients (2018)
Kirchberger MC, Moreira A, Erdmann M, et al.

Journal issue: 12, Volume: 9, Pages range: 10445-10456
Selenium-binding protein 1 is down-regulated in malignant melanoma (2018)
Schott M, de Jel MM, Engelmann JC, et al.

Last updated on 2019-25-04 at 14:43